7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies
7-hydroxy-2-N,N-dipropylaminotetralin: RN given refers to cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Kampen, JM | 1 |
| Eckman, CB | 1 |
| Sánchez-Pernaute, R | 1 |
| Jenkins, BG | 1 |
| Choi, JK | 1 |
| Iris Chen, YC | 1 |
| Isacson, O | 1 |
2 other studies available for 7-hydroxy-2-n,n-dipropylaminotetralin and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Dopamine D3 receptor agonist delivery to a model of Parkinson's disease restores the nigrostriatal pathway and improves locomotor behavior.
Topics: Animals; Cell Division; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Female; Motor Ac | 2006 |
In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias.
Topics: Animals; Brain; Cerebrovascular Circulation; Dopamine Agents; Dyskinesia, Drug-Induced; Levodopa; Ma | 2007 |